Unravelling Toxoplasma treatment: conventional drugs toward nanomedicine

被引:12
作者
Azami, Sanaz Jafarpour [1 ,2 ]
Rahimi, Hanieh Mohammad [1 ]
Mirjalali, Hamed [1 ]
Zali, Mohammad Reza [3 ]
机构
[1] Shahid Beheshti Univ Med Sci, Res Inst Gastroenterol & Liver Dis, Foodborne & Waterborne Dis Res Ctr, Tehran, Iran
[2] Univ Tehran Med Sci, Sch Publ Hlth, Dept Med Parasitol & Mycol, Tehran, Iran
[3] Shahid Beheshti Univ Med Sci, Res Inst Gastroenterol & Liver Dis, Gastroenterol & Liver Dis Res Ctr, Tehran, Iran
关键词
Toxoplasma gondii; Acute toxoplasmosis; Chronic toxoplasmosis; Treatment; Conventional therapy; Nanomedicine; CHITOSAN NANOPARTICLES; SILVER NANOPARTICLES; GONDII TACHYZOITES; ATOVAQUONE; NANOSILVER; INFECTION; MODEL;
D O I
10.1007/s11274-021-03000-x
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Toxoplasma gondii is a worldwide protozoan parasite that infects almost all warm-blooded animals. Although human toxoplasmosis is mostly latent, pregnant women and immunocompromised patients need effective treatment. There are drugs of choice for treatment of toxoplasmosis; however, due to their side effects and/or their disease stage-specificity, prescription of them is limited. During recent years, nanomedicine has been employed to overcome limitations of conventional drugs. Here, we provided a state-of-the-art review of experimental toxoplasmosis treatment using nanotechnology.Graphic abstract
引用
收藏
页数:9
相关论文
共 63 条
[1]   Nanoparticles show potential to retard bradyzoites in vitro formation of Toxoplasma gondii [J].
Adeyemi, Oluyomi Stephen ;
Murata, Yuho ;
Sugi, Tatsuki ;
Han, Yongmei ;
Kato, Kentaro .
FOLIA PARASITOLOGICA, 2019, 66
[2]   Metal nanoparticles restrict the growth of protozoan parasites [J].
Adeyemi, Oluyomi Stephen ;
Molefe, Nthatisi Innocentia ;
Awakan, Oluwakemi Josephine ;
Nwonuma, Charles Obiora ;
Alejolowo, Omokolade Oluwaseyi ;
Olaolu, Tomilola ;
Maimako, Rotdelmwa Filibus ;
Suganuma, Keisuke ;
Han, Yongmei ;
Kato, Kentaro .
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2018, 46 :S86-S94
[3]   Inorganic nanoparticles kill Toxoplasma gondii via changes in redox status and mitochondrial membrane potential [J].
Adeyemi, Oluyomi Stephen ;
Murata, Yuho ;
Sugi, Tatsuki ;
Kato, Kentaro .
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2017, 12 :1647-1661
[4]   Anti-Toxoplasma activity of silver nanoparticles green synthesized with Phoenix dactylifera and Ziziphus spina-christi extracts which inhibits inflammation through liver regulation of cytokines in Balb/c mice [J].
Alajmi, Reem A. ;
AL-Megrin, Wafa A. ;
Metwally, Dina ;
AL-Subaie, Hind ;
Altamrah, Nourah ;
Barakat, Ashraf M. ;
Moneim, Ahmed E. Abdel ;
Al-Otaibi, Tahani T. ;
El-Khadragy, Manal .
BIOSCIENCE REPORTS, 2019, 39
[5]   Drugs in development for toxoplasmosis: advances, challenges, and current status [J].
Alday, P. Holland ;
Doggett, Joseph Stone .
DRUG DESIGN DEVELOPMENT AND THERAPY, 2017, 11 :273-293
[6]   Host persistence:: Exploitation of anti-inflammatory pathways by Toxoplasma gondii [J].
Aliberti, J .
NATURE REVIEWS IMMUNOLOGY, 2005, 5 (02) :162-170
[7]   Curcumin nanoemulsion as a novel chemical for the treatment of acute and chronic toxoplasmosis in mice [J].
Azami, Sanaz Jafarpour ;
Teimouri, Aref ;
Keshavarz, Hossein ;
Amani, Amir ;
Esmaeili, Fariba ;
Hasanpour, Hamid ;
Elikaee, Samira ;
Salehiniya, Hamid ;
Shojaee, Saeedeh .
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2018, 13 :7363-7374
[8]   Nanoemulsion of atovaquone as a promising approach for treatment of acute and chronic toxoplasmosis [J].
Azami, Sanaz Jafarpour ;
Amani, Amir ;
Keshavarz, Hossein ;
Najafi-Taher, Roqya ;
Mohebali, Mehdi ;
Faramarzi, Mohammad Ali ;
Mahmoudi, Mahmood ;
Shojaee, Saeedeh .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 117 :138-146
[9]   Antiparasitic agent atovaquone [J].
Baggish, AL ;
Hill, DR .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (05) :1163-1173
[10]  
Bahadar Haji, 2016, Iranian Biomedical Journal, V20, P1, DOI 10.7508/ibj.2016.01.001